학술논문

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

Document Type

Article

Author

Danese, S.; Panaccione, R.; Feagan, B.G.; Afzali, A.; Rubin, D.T.; Sands, B.E.; Reinisch, W.; Panés, J.; Sahoo, A.; Terry, N.A.; Han, C.; Frustaci, M.E.; Yang, Z.; Chan, D.; Sandborn, W.J.; Hisamatsu, T.; Andrews, J.M.; D'Haens, G.R.

Source

In: The Lancet Gastroenterology and Hepatology. (The Lancet Gastroenterology and Hepatology, February 2024, 9(2):133-146)

Subject

Language

English

ISSN

24681253

Online Access

Full Text (ScienceDirect 종량제) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송